Status:
COMPLETED
Effect of DHA on Proinflammatory Cytokines Including Platelets Activating Factor (PAF) in Preterm Neonates
Lead Sponsor:
Ain Shams University
Conditions:
Neonatal Disease
Eligibility:
All Genders
1-28 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether docosahexaenoic acid is effective in the prevention or reducing severity of necrotizing enterocolitis in preterm/low birth weight neonates.Necrotizing...
Detailed Description
Inclusion criteria: Patients are eligible for inclusion if they meet the following criteria: Preterm neonates having a gestational age equal or less than 32 weeks at birth, admitted in Ain Shams Uni...
Eligibility Criteria
Inclusion
- Preterm neonates having a gestational age equal or less than 32 weeks at birth, admitted in Ain Shams University NICU'S.
- Weight (less than or equal 1.500 KG) Clinically stable to begin enteral feeding All Genders (Male, Female) Written informed consent by parents Sepsis will not be considered as exclusion criteria (according to SNAP 11; this score considers six physiologic variables such as blood pressure, temperature, the Po2/Fio2 ratio, serum PH, seizures and urine output, Töllner score (table 3) and Rodwell score
Exclusion
- Persistent bleeding at any level. Receiving medication to avoid coagulation. Persistent vomiting. Gastrointestinal malformations. Mother taking Omega-3 supplements and planning to breastfed.
Key Trial Info
Start Date :
September 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04746885
Start Date
September 21 2017
End Date
January 1 2021
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 11566